1. Redo surgical aortic valve replacement for prosthetic valve valve‐in‐valve dysfunction
- Author
-
Giuseppe Tavilla, Amber Malhotra, Brady Gunn, Daniel L. Beckles, and Ramachandra C. Reddy
- Subjects
Bioprosthesis ,Heart Valve Prosthesis Implantation ,Reoperation ,Pulmonary and Respiratory Medicine ,Aortic Valve Stenosis ,Prosthesis Design ,Transcatheter Aortic Valve Replacement ,Treatment Outcome ,Risk Factors ,Aortic Valve ,Heart Valve Prosthesis ,Humans ,Female ,Surgery ,Cardiology and Cardiovascular Medicine ,Aged - Abstract
Transcatheter aortic valve replacement (TAVR) has become the preferred intervention for patients with severe aortic stenosis and significant comorbidities. This technique can also be used for failed bioprosthetic valves and is known as the valve-in-valve (ViV) procedure. Placing TAVR in a small bioprosthesis (23 mm) can lead to delayed dysfunction of the prosthetic valve. We present a case of a late explanted ViV 8 years post-initial aortic valve replacement and coronary artery bypass grafting, and 3 years post-ViV procedure in a 76-year-old female. A video of the surgical procedure is provided.
- Published
- 2022
- Full Text
- View/download PDF